Back
First Busey Vs. Avidity Biosciences Industry Stock Comparison
Buy
77
BUSE
First Busey
Last Price:
27.46
Seasonality Move:
5.64%
Sell
31
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-6.96%
Buy
77
First Busey (BUSE)
is a Buy
Is First Busey a Buy, Sell or Hold?
- The current First Busey [BUSE] share price is $26.76. The Score for BUSE is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- BUSE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $44.64. The Score for RNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BUSE Stock Price Chart
What is First Busey's stock price today?
-
The First Busey share price today is $26.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BUSE is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $44.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BUSE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 55.53 | Buy |
| Chaikin Money Flow: | -89877 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.65 - 27.03) | Buy |
| Bollinger Bands (100): | (22.79 - 26.55) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 58.78 | Buy |
| Chaikin Money Flow: | 2358339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.17 - 44.49) | Buy |
| Bollinger Bands (100): | (30.01 - 45.23) | Buy |
BUSE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.22 | Buy |
| 20-day SMA: | 26.54 | Buy |
| 50-day SMA: | 26.32 | Buy |
| 200-day SMA: | 24.09 | Buy |
| 8-day EMA: | 26.43 | Buy |
| 20-day EMA: | 26.34 | Buy |
| 50-day EMA: | 25.87 | Buy |
| 200-day EMA: | 24.1 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.71 | Buy |
| 20-day SMA: | 42.36 | Buy |
| 50-day SMA: | 43.76 | Buy |
| 200-day SMA: | 26.77 | Buy |
| 8-day EMA: | 42.29 | Buy |
| 20-day EMA: | 42.39 | Buy |
| 50-day EMA: | 41.68 | Buy |
| 200-day EMA: | 30.34 | Buy |
First Busey Earnings Growth & BUSE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.17 per share, a decrease this year of $0.18 per share, and an increase next year of $0.53 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
First Busey Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||